Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022
Revenues2.2b2.2b-4.0b2.0b3.8b4.3b
% growth(21 %)(1 %)--(50 %)92 %11 %
EBITDA2.3b2.3b(1.4b)4.5b656m3.5b823m
% EBITDA margin103 %107 %-114 %33 %90 %19 %
Profit2.3b1.9b(1.4b)4.5b647m3.5b791m
% profit margin103 %84 %-113 %32 %90 %19 %

Recent News about ViiV Healthcare

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by ViiV Healthcare

Edit
Idenix Pharmaceuticals
ACQUISITION by Merck Jun 2014